ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: full text: A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society

Fuster, Valentín; Rydén, Lars; Cannom, David S.; Crijns, Harry J.G.M.; Curtis, Anne B.; Ellenbogen, Kenneth A.; Halperin, Jonathan L.; Heuzey, J.-Y. Le; Kay, G. Neal; Lowe, James E.; Olsson, Sandra; Prystowsky, Eric N.; Tamargo, Juan; Wann, Samuel; Smith, Sidney C.; Jacobs, Alice K.; Adams, Cynthia D.; Anderson, J. Lawford; Antman, Elliott M.; Hunt, Sharon A.; Nishimura, Rick A.; Ornato, Joseph P.; Page, Richard L.; Riegel, Bárbara; Priori, Silvia G.; Blanc, Jean Jacques; Budaj, Andrzej; Camm, A. John; Dean, Veronica; Deckers, Jaap W.; Despres, Catherine; Dickstein, Kenneth; Lekakis, John; McGregor, Keith; Metra, Marco; Morais, João; Osterspey, A.; Zamorano, José Luís

doi:10.1093/europace/eul097

Cited by 903 publications

(1,030 citation statements)

References 874 publications

Supporting

Mentioning

907

Contrasting

Unclassified

113

Order By: Relevance

“…The diagnosis of AF: All selected patients were NVAF confirmed by TEE or transthoracic echocardiography (TTE), without the history of rheumatic mitral stenosis, a mechanical or bioprosthemic heart valve replacement or mitral valvoplasty. The clinical diagnosis of AF was made with respect to the AHA/ACC/HRS guideline for the management of patients with AF in 2006, 13) updated in 2011 14) and 2014. 15) The process of clinical diagnosis was completed with more than two experienced doctors working in our hospital, according to episodes of AF in routine 12-lead electrocardiogram (ECG) or 24 hours ECG Holter monitoring at least once or the clear history of AF.…”

Section: Study Populationmentioning

confidence: 99%

The Refinement of Risk Stratification for Atrial Thrombus or Spontaneous Echo Contrast in Nonvalvular Atrial Fibrillation

Ning

et al. 2017

Int. Heart J.

View full text Add to dashboard Cite

SummaryAs for nonvalvular atrial fibrillation (NVAF) patients with left atrial thrombus or spontaneous echo contrast (LAT/SEC), we evaluated the additional predictive value of serum uric acid (SUA) and Left atrial diameter (LAD) for CHADS2 and CHA2DS2-VASc, and explored the influence from the level of SUA and LAD to LAT/ SEC in moderate risk group. Thus, we put forward the concept of a borderline high risk group to guide clinical anticoagulant therapy in patients with NVAF.A total of 284 NVAF patients without the history of anticoagulant prior to hospitalization were enrolled. They were divided into LAT/SEC group or No LAT/SEC group according to transesophageal echocardiography (TEE). Then, we explored and compared the additional predictive value of serological and ultrasonic indexes after combining them to CHADS2/CHA2DS2-VASc.61 patients (21.48%) had LAT/SEC. SUA and LAD were the independent risk factors of LAT/SEC. After being added with LAD and SUA, the predictive value of CHADS2 and CHA2DS2-VASc were increased much more than others. In the moderate risk group, the incidence of LAT/SEC rose significantly when SUA or LAD was higher than cut-off values.SUA and LAD enhanced the predictive ability of CHADS2 and CHA2DS2-VASc for LAT/SEC as additional factors. For patients in moderate risk group, if SUA or LAD was higher than cut-off values, the risk of thromboembolism events would rise accompanied by the elevated risk of LAT/SEC.(Int Heart J 2017; 58: 885-893) Key words: Predictive value, Left atrial thrombus, Borderline high risk group A trial fibrillation (AF) is the most common arrhythmia, affecting approximately 8 million patients in China.1) Meanwhile, its morbidity is increasing with the aging population as well as the morbidity of cardiovascular disease year by year. Cardiac stroke accounted for about a quarter of all patients with stroke, and more than half of them were caused by AF.2) AF increased the risk of stroke by five times. Among them, more than 90% of embolism comes from left atrial appendage (LAA). Therefore, preventing thrombus in LAA can reduce the morbidity of stroke, and it can be used as a substitute to prevent patients with AF from stroke in earlier stage.At present, CHADS2 scores and CHA2DS2-VASc scores are widely accepted and practical clinical stroke risk stratifications. Recently, some researches have shown that CHADS2 and CHA2DS2-VASc scores not only predict stroke risk, but also have an obvious relationship with LAT and can be used to predict the formation of LAT. [3][4][5][6] However, Yarmohammadi, et al. 4) found that patients with a score of 0 or 1 point in CHADS2 accounted for almost a third of the total with atrial thrombus. In addition, a prospective study including 295 NVAF patients with 0 or 1 point CHADS2 score were followed up, onaverage for 5 years. The results showed that 3% of the patients had LAT and 8% of patients had SEC. 7) By adding some additional risk factors to CHADS2 and CHA2DS2-VASc score, especially in patients who should have anticoagulant therapy but were i...

show abstract

Section: Study Populationmentioning

confidence: 99%

The Refinement of Risk Stratification for Atrial Thrombus or Spontaneous Echo Contrast in Nonvalvular Atrial Fibrillation

Ning

et al. 2017

Int. Heart J.

View full text Add to dashboard Cite

show abstract

“…34 Previous reports have shown that AF incidences varies with severity of systolic dysfunction among the heart failure patients. 35 There is strong association between duration of QRS complex and AF. EL-Chami et al documented this relation in his study named "QRS Duration Is Associated with Atrial Fibrillation in Patients with Left Ventricular Dysfunction".…”

Section: Discussionmentioning

confidence: 99%

Heart Failure; Co-Relation of QRS Duration With Atrial Fibrillation in Patients With Reduced Ejection Fraction

Mir

Asghar²,

Javed

2017

TPMJ

View full text Add to dashboard Cite

ABSTRACT… Introduction: Atrial fibrillation (AF) and wider QRS duration have long been identified to worsen heart failure and LV dysfunction and increase cardiovascular morbidity and mortality. Therefore, it is necessary to identify those patients of heart failure who are at greater risk for cardiovascular morbidity and mortality so that such subjects may be focused for preventive strategies. An association exists between QRS duration and AF with greater incidences of cardiovascular events in patients of heart failure with LV systolic dysfunction. Sampling technique was non-probability, purposive sampling. Result: The study population consisted of male (72.3%) and female (27.7%). Mean LA diameter was 40.3±6.08 mm and mean LV ejection fraction 31.8±6.6 % in the study population. Ischemic heart disease was the most common cause of LV dysfunction (88.3%) followed by non-ischemic cardiomyopathy (8.75%) and non-Ischemic valvular heart disease (3.5%). The frequency of Narrow QRSd (<120 ms) was 62%, Intermediate QRSd (120-150 ms) was 26.5% and Wide QRSd (>150 ms) was 11.5%. The frequency of atrial fibrillation in study population was 15.75%. The frequency of atrial fibrillation was highest in Wide QRSd group (>150 ms) i.e. (60.9%), followed by Intermediate QRSd group (120-150 ms) i.e. (18.9%) and narrow QRSd group (<120 ms) i.e. (6.04%). Patient with atrial fibrillation were more likely to have poor ejection fraction (P<0.0023) and wider QRS duration (P<0.0001). Frequency of atrial fibrillation was highest in Valvular Cardiomyopathy (non-ischemic valvular heart disease) patients (42.8%) as compared to coronary artery disease group (15.3%) and non-ischemic cardimyopathy group (9.4%). Conclusion: In patients of heart failure with reduced ejection fraction (HFrEF), the frequency of atrial fibrillation increases as QRS duration widens. This group of patients must be focused for AF preventive strategies. Key words:Atrial fibrillation (AF), Left ventricular (LV), QRS duration (QRSd). Article Citation: Mir N, Asghar N, Javed S. Heart failure; co-relation of QRS duration with atrial fibrillation in patients with reduced ejection fraction. Professional Med J 2017;24(6):912-918.

show abstract

“…According to the American College of Cardiology/American Heart Association/European Society of Cardiology (ACC/AHA/ESC) 2001 guidelines, NVAF was defined as rhythm disturbance occurring in the absence of rheumatic mitral valve disease or a prosthetic heart valve 16. In the 2006 update to these guidelines, the definition was revised to include AF in the absence of mitral valve repair 17. The ACC/AHA/Heart Rhythm Society (HRS) 2014 guidelines define NVAF as AF in the absence of rheumatic mitral stenosis, a mechanical or bioprosthetic heart valve, or mitral valve repair 18.…”

Section: Evolving Definitions Of Nvafmentioning

confidence: 99%

Use of Direct Oral Anticoagulants in Patients With Atrial Fibrillation and Valvular Heart Lesions

Biase

2016

JAHA

View full text Add to dashboard Cite

Cited by 903 publications

References 874 publications

The Refinement of Risk Stratification for Atrial Thrombus or Spontaneous Echo Contrast in Nonvalvular Atrial Fibrillation

The Refinement of Risk Stratification for Atrial Thrombus or Spontaneous Echo Contrast in Nonvalvular Atrial Fibrillation

Heart Failure; Co-Relation of QRS Duration With Atrial Fibrillation in Patients With Reduced Ejection Fraction

Use of Direct Oral Anticoagulants in Patients With Atrial Fibrillation and Valvular Heart Lesions

Contact Info

Product

Resources

About